AzTrials
AzTrials

Blood PressurePhase 2NCT02119429

Pumpkin Seed Oil Supplementation in Premenopausal Women

A Phase 2 study testing Pumpkin Seed Oil and Wheat Germ Oil in people with Blood Pressure, run by Texas Woman's University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether or not there is an effect of pumpkin seed oil supplementation, 2 grams per day, on blood pressure (systolic and diastolic) in premenopausal women. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Blood Pressure
What is being tested?
Pumpkin Seed Oil and Wheat Germ Oil
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
50 participants
Where
1 siteUnited States
Study dates
Apr 2014to May 2015
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Read, speak, and write English
  • Premenopausal

Who cannot join

  • Consuming estrogen supplements
  • Taking hypertensive blood pressure medication
  • Consuming pumpkin seed oil supplements
  • Consuming pumpkin seeds more than once a month
  • Wheat allergy or gluten intolerance
  • Blood pressure > 140/90 mmHg

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Texas Woman's University, Institute of Health Sciences- Houston Center

    Houston, Texas, 77030

Other trials in United States

About this study

Official title: The Effect of Pumpkin Seed Oil Supplementation on Blood Pressure in Premenopausal Women

The purpose of this study is to determine whether or not there is an effect of pumpkin seed oil supplementation, 2 grams per day, on blood pressure (systolic and diastolic) in premenopausal women.

Read the detailed description

The research study will be conducted over a 12-week period. Overall, each participant will meet with the researcher three times. During the first visit, after the participant has signed the consent form, their blood pressure will be taken with a digital blood pressure monitor. If her systolic blood pressure is greater than 140 mmHg or her diastolic blood pressure is greater than 90 mmHg, she will not be eligible to take part in this study. If the participant is able to take part in this study, she will be given a code number to protect confidentiality and randomly assigned to one of two groups, Group I or Group II. The participant will then be asked to state their age, ethnicity, menopausal status, and whether or not they are taking oral contraceptives. Next, height and weight will be taken with an instrument called a Health-O-Meter. Body mass index (BMI) and percent body fat will be calculated using an instrument called a Body Composition Analyzer. After all measurements are taken, participants will be given instructions on how to keep a 3-day diet and supplement diary. A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day. The 3-day diet and supplement diary is to be completed during the week between the first and second session with the researcher. During this session the participant will be asked to complete a food frequency questionnaire to help the researcher asses the phytoestrogen content of her diet. At the end of the first session, the researcher will schedule a second session with the participant.

The second session will take place one week after the first session. During the second session, measurements taken will be height, weight, BMI, percent body fat, and blood pressure. Participants will be asked to return the 3-day diet and supplement diary to the researcher. The researcher will review the diary and ask questions to clarify foods recorded. The participant will then be asked to complete a physical activity questionnaire. Next, supplements will be distributed. The participants will not have knowledge of which group they are assigned to. Group I will receive 168 capsules, each capsule containing 1 gram of wheat germ oil, in two pill bottles. One bottle will contain 100 capsules; the second bottle will contain 68 capsules. Group II will receive 168 capsules, each capsule containing 1 gram of pumpkin seed oil, in two pill bottles. One bottle will contain 100 capsules; the second bottle will contain 68 capsules. Participants will be instructed to take 2 capsules per day, every day for 12 weeks. Two capsules per day are equal to approximately a ½ teaspoon or 18 kilocalories. It does not matter if they choose to take each capsule at the same time or at different times during the day. To help remind participants to take their supplements each day, they will receive a 7 day pill organizer and a daily check list. At this session, participants will receive a second 3-day diet and supplement diary that is to be completed one week before the final session. At the end of the second session, the researcher will schedule the final session with the participant.

The third and final session will take place 12 weeks after the initial session. Measurements taken during the final session will be height, weight, BMI, percent body fat, and blood pressure. The participant will be asked to complete a food frequency questionnaire identical the questionnaire filled out during the first session with the researcher. Participant will be asked to return their 3-day diet and supplement diary, daily check list, pill organizer, 2 pill bottles, and any unused supplements. After completion of the study the participant will receive a $20 Target gift card at this session.

A potential risk of this study includes loss of confidentiality. Confidentiality will be maintained by the use of code numbers rather than names on data containing documents. Digital data analyses will be done using only code numbers and not identifiable data. Data recorded on paper containing identifiable and non-identifiable participant information (consent forms, data collection forms, 3-day diet and supplement diaries, physical activity questionnaires, food frequency questionnaires, and participant daily checklists) will be kept in a locked cabinet in Room 10132B in the Texas Woman's University, Houston Office of Research.

Another potential risk of this study may be that the participant's normal schedule is disrupted by coming to the Texas Woman's University, Houston campus. To minimize this risk, sessions will be scheduled with the researcher in advance Monday through Friday, from 8 a.m. to 5 p.m. to accommodate the participant's schedule.

Conditions
Blood Pressure
Being tested
Pumpkin Seed Oil, Wheat Germ Oil
Keywords
Blood pressure, Pre-menopausal, Supplementation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pumpkin Seed OilDietary supplement

    2 grams per day, everyday for 12 weeks.

  • Wheat Germ OilDietary supplement

    2 grams per day, everyday for 12 weeks.

Study groups in NCT02119429
Study groupRoleWhat they receive
Wheat Germ OilPlacebo comparatorParticipants will be instructed to consume 2 wheat germ oil capsules ,2g, per day for 12 weeks.
Receives: Dietary Supplement: Wheat Germ Oil
Pumpkin Seed OilExperimentalParticipants will be instructed to consume 2 pumpkin seed oil capsules ,2g, per day for 12 weeks
Receives: Dietary Supplement: Pumpkin Seed Oil

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change From Baseline Systolic Blood Pressure at 12 weeks

    Measured: Baseline, 12 weeks

  2. Change From Baseline Diastolic Blood Pressure at 12 weeks

    Measured: Baseline, 12 weeks

Secondary outcomes (10)
  1. Body Mass Index (BMI)

    BMI is an important measurement to record because an increase in weight may be accompanied by an increase in blood pressure.

    Measured: Baseline

  2. Percent Body Fat

    Percent body fat is an important measurement to record because an increase in body fat may be accompanied by an increase in blood pressure.

    Measured: Baseline

  3. Nutrient content of diet

    Participants will be given instructions on how to keep a 3-day diet and supplement diary. A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day. Diet will then be analyzed using Minnesota Nutrition Data System for calories, carbohydrate, protein, fat, vitamins, minerals, and phytoestrogen content.

    Measured: Baseline

  4. Phytoestrogen content of diet

    A food frequency questionnaire will be given to each participants to assess the phytoestrogen content of her diet.

    Measured: Baseline

  5. Activity Level

    The purpose of the physical activity questionnaire is to establish each participant's activity level because physical activity level may have an effect on blood pressure.

    Measured: Baseline

  6. Body Mass Index (BMI)

    BMI is an important measurement to record because an increase in weight may be accompanied by an increase in blood pressure.

    Measured: 12 weeks

  7. Percent Body Fat

    Percent body fat is an important measurement to record because an increase in body fat may be accompanied by an increase in blood pressure.

    Measured: 12 weeks

  8. Nutrient content of diet

    Participants will be given instructions on how to keep a 3-day diet and supplement diary. A booklet will be provided to help them record their diet for two nonconsecutive week days and one weekend day. Diet will then be analyzed using Minnesota Nutrition Data System for calories, carbohydrate, protein, fat, vitamins, minerals, and phytoestrogen content.

    Measured: 12 weeks

  9. Phytoestrogen content of diet

    A food frequency questionnaire will be given to each participants to assess the phytoestrogen content of her diet.

    Measured: 12 weeks

  10. Activity Level

    The purpose of the physical activity questionnaire is to establish each participant's activity level because physical activity level may have an effect on blood pressure.

    Measured: 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2014 (estimated)
  2. Study startApr 2014
  3. Primary completionMay 2015
  4. Study completionMay 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02119429
Sponsor's protocol ID
17411a
Status last verified
Dec 2014
First submitted
15 Apr 2014
Last updated
18 Jun 2015
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing Pumpkin Seed Oil and Wheat Germ Oil in people with Blood Pressure, run by Texas Woman's University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change From Baseline Systolic Blood Pressure at 12 weeks (time frame: Baseline, 12 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in